申请人:Bayer Pharma Aktiengesellschaft
公开号:US20200339606A1
公开(公告)日:2020-10-29
A process for preparing the benzothiophen-2-yl boronate of formula (VI) which serves as an intermediate for production of medicaments and for production of medicaments for treatment and/or prophylaxis of proliferative disorders, such as cancer and tumor diseases.